Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9591)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Novo-Veleiro I, Alvela-Suárez L, Chamorro AJ, González-Sarmiento R, Laso FJ, Marcos M. Alcoholic liver disease and hepatitis C virus infection. World J Gastroenterol 2016; 22(4): 1411-1420 [PMID: 26819510 DOI: 10.3748/wjg.v22.i4.1411] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1411.htm |
| Number | Citing Articles |
| 1 |
Jonathan Chow, Zsuzsa Márka, Imre Bartos, Szabolcs Márka, Jonathan C. Kagan. Environmental Stress Causes Lethal Neuro-Trauma during Asymptomatic Viral Infections. Cell Host & Microbe 2017; 22(1): 48 doi: 10.1016/j.chom.2017.06.010
|
| 2 |
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Annals of Hepatology 2019; 18(3): 518 doi: 10.1016/j.aohep.2019.04.005
|
| 3 |
Baozhang Shi, Jinqiang Qian, Hongyue Miao, Shuo Zhang, Yue Hu, Puqing Liu, Liping Xu. Mulberroside A ameliorates CCl4‐induced liver fibrosis in mice via inhibiting pro‐inflammatory response. Food Science & Nutrition 2023; 11(6): 3433 doi: 10.1002/fsn3.3333
|
| 4 |
Xinyi Jiang, Hyun Jin Song, Ching-Yuan Chang, Debbie L. Wilson, Wei-Hsuan Lo-Ciganic, Haesuk Park. Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C. Medical Care 2023; 61(8): 505 doi: 10.1097/MLR.0000000000001870
|
| 5 |
Shazia Tabassum Hakim, Cayatineto HW. Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitors. Journal of Human Virology & Retrovirology 2024; 11(1): 36 doi: 10.15406/jhvrv.2024.11.00278
|
| 6 |
Benjamin J. Mahoney, Kenneth L. Morford, Emma T. Biegacki, Jeanette M. Tetrault. Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000241
|
| 7 |
F. Roesch-Dietlen, M. González-Santes, Y.J. Sánchez-Maza, F. Díaz-Roesch, A.D. Cano-Contreras, M. Amieva-Balmori, K.R. García-Zermeño, L. Salgado-Vergara, J.M. Remes-Troche, S. Ortigoza-Gutiérrez. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver. Revista de Gastroenterología de México (English Edition) 2021; 86(1): 28 doi: 10.1016/j.rgmxen.2020.01.004
|
| 8 |
P. V. AshaRani, Mohamed Zakir Karuvetil, Tan Yeow Wee Brian, Pratika Satghare, Kumarasan Roystonn, Wang Peizhi, Laxman Cetty, Noor Azizah Zainuldin, Mythily Subramaniam. Prevalence and Correlates of Physical Comorbidities in Alcohol Use Disorder (AUD): a Pilot Study in Treatment-Seeking Population. International Journal of Mental Health and Addiction 2023; 21(4): 2508 doi: 10.1007/s11469-021-00734-5
|
| 9 |
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller. Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection. Clinical and Molecular Hepatology 2023; 29(1): 1 doi: 10.3350/cmh.2022.0017
|
| 10 |
Natalia A. Osna, Rakesh Bhatia, Christopher Thompson, Surinder K. Batra, Sushil Kumar, Yeonhee Cho, Gyongyi Szabo, Patricia E. Molina, Steven A. Weinman, Murali Ganesan, Kusum K. Kharbanda. Role of non-Genetic Risk Factors in Exacerbating Alcohol-related organ damage. Alcohol 2020; 87: 63 doi: 10.1016/j.alcohol.2020.05.002
|
| 11 |
Fabiane Mateus Siqueira, Vinicius Lins Ferreira, Helena Hiemisch Lobo Borba, Roberto Pontarolo. Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapies. Revista do Instituto de Medicina Tropical de São Paulo 2018; 60(0) doi: 10.1590/s1678-9946201860072
|
| 12 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 13 |
Murali Ganesan, Allison Eikenberry, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Role of alcohol in pathogenesis of hepatitis B virus infection. World Journal of Gastroenterology 2020; 26(9): 883-903 doi: 10.3748/wjg.v26.i9.883
|
| 14 |
Koichiro Ohashi, Michael Pimienta, Ekihiro Seki. Alcoholic liver disease: A current molecular and clinical perspective. Liver Research 2018; 2(4): 161 doi: 10.1016/j.livres.2018.11.002
|
| 15 |
|
| 16 |
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World Journal of Gastroenterology 2017; 23(36): 6549-6570 doi: 10.3748/wjg.v23.i36.6549
|
| 17 |
Suyan G.R. dos Santos, Angelo A. Mattos, Marcela M. Guimarães, Bibiana de S. Boger, Gabriela P. Coral. Alcohol Consumption Influences Clinical Outcome in Patients Admitted to a Referral Center for Liver Disease. Annals of Hepatology 2018; 17(3): 470 doi: 10.5604/01.3001.0011.7391
|
| 18 |
Silvia Andaloro, Fabrizio Mancuso, Luca Miele, Giovanni Addolorato, Antonio Gasbarrini, Francesca Romana Ponziani. Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease. Nutrients 2024; 16(5): 613 doi: 10.3390/nu16050613
|
| 19 |
Zixiong Zhou, Jing Qi, Jong-Won Kim, Myung-jo You, Chae Woong Lim, Bumseok Kim. AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity in vivo and in vitro. Toxicology Mechanisms and Methods 2020; 30(5): 324 doi: 10.1080/15376516.2020.1729915
|
| 20 |
Mariya S. Pravdivtseva, Oleg B. Shevelev, Vadim V. Yanshole, Mikhail P. Moshkin, Igor V. Koptyug, Andrey E. Akulov. In Vitro 1H NMR Metabolic Profiles of Liver, Brain, and Serum in Rats After Chronic Consumption of Alcohol. Applied Magnetic Resonance 2021; 52(6): 661 doi: 10.1007/s00723-021-01338-x
|
| 21 |
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV Infection. Journal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
|
| 22 |
Neil D. Theise, Henry Charles Bodenheimer, Maria Guido. Macsween's Pathology of the Liver. 2018; : 372 doi: 10.1016/B978-0-7020-6697-9.00006-6
|
| 23 |
Sasha Hermosa, Stelliana Goutzamanis, Joseph Doyle, Peter Higgs. Reducing alcohol-related harm in people recently treated for hepatitis C. Australian Journal of Primary Health 2019; 25(3): 193 doi: 10.1071/PY19074
|
| 24 |
Hideki Fujii, Naoki Nishimoto, Seiko Yamaguchi, Osamu Kurai, Masato Miyano, Wataru Ueda, Hiroko Oba, Tetsuya Aoki, Norifumi Kawada, Kiyotaka Okawa. The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study. BMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-3053-6
|
| 25 |
James C. Barton, J. Clayborn Barton, Paul C. Adams. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes. Annals of Hepatology 2019; 18(2): 354 doi: 10.1016/j.aohep.2018.11.005
|
| 26 |
Lin Zhu, Hai-Di Li, Jie-Jie Xu, Juan-Juan Li, Miao Cheng, Xiao-Ming Meng, Cheng Huang, Jun Li. Advancements in the Alcohol-Associated Liver Disease Model. Biomolecules 2022; 12(8): 1035 doi: 10.3390/biom12081035
|
| 27 |
Akshata Moghe, Shirish S. Barve, Craig J. McClain, Swati Joshi-Barve. Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV. Cellular and Molecular Gastroenterology and Hepatology 2018; 5(2): 163 doi: 10.1016/j.jcmgh.2017.11.009
|
| 28 |
Wen-Jun Wang, Peng Xiao, Hong-Qin Xu, Jun-Qi Niu, Yan-Hang Gao. Growing burden of alcoholic liver disease in China: A review. World Journal of Gastroenterology 2019; 25(12): 1445-1456 doi: 10.3748/wjg.v25.i12.1445
|
| 29 |
F. Roesch-Dietlen, M. González-Santes, Y.J. Sánchez-Maza, F. Díaz-Roesch, A.D. Cano-Contreras, M. Amieva-Balmori, K.R. García-Zermeño, L. Salgado-Vergara, J.M. Remes-Troche, S. Ortigoza-Gutiérrez. Influencia de los factores socioeconómicos y culturales en la etiología de la cirrosis hepática. Revista de Gastroenterología de México 2021; 86(1): 28 doi: 10.1016/j.rgmx.2020.01.002
|
| 30 |
Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez-Pinto. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Journal of Hepatology 2018; 69(1): 154 doi: 10.1016/j.jhep.2018.03.018
|
| 31 |
Haesuk Park, Xinyi Jiang, Hyun Jin Song, Vincent Lo Re, Lindsey M. Childs‐Kean, Wei‐Hsuan Lo‐Ciganic, Robert L. Cook, David R. Nelson. The Impact of Direct‐Acting Antiviral Therapy on End‐Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders. Hepatology 2021; 74(2): 566 doi: 10.1002/hep.31732
|
| 32 |
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
|
| 33 |
Ashakumary Lakshmikuttyamma, Sidhartha D. Ray, Abigail Kay. . Side Effects of Drugs Annual 2016; doi: 10.1016/bs.seda.2016.08.023
|
| 34 |
Laura Llamosas-Falcón, Kevin D. Shield, Maya Gelovany, Jakob Manthey, Jürgen Rehm. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review. Substance Abuse Treatment, Prevention, and Policy 2020; 15(1) doi: 10.1186/s13011-020-00287-1
|
| 35 |
Paula Chaves Mari, Reema Gulati, Philip Fragassi. Adolescent Hepatitis C: Prevalence, Impact, and Management Challenges. Adolescent Health, Medicine and Therapeutics 2021; : 45 doi: 10.2147/AHMT.S263864
|
| 36 |
Kairi Mansberg, Karin Kull, Riina Salupere, Tiina Prükk, Benno Margus, Toomas Kariis, Triin Remmel, Külliki Suurmaa, Kristi Ott, Krista Jaago, Jelena Šmidt. A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia. Medicina 2018; 54(1): 9 doi: 10.3390/medicina54010009
|
| 37 |
Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada. Hepatitis B virus infection and alcohol consumption. World Journal of Gastroenterology 2017; 23(15): 2651-2659 doi: 10.3748/wjg.v23.i15.2651
|
| 38 |
Jiadi Wu, Daqiang Wu, Kelong Ma, Tianming Wang, Gaoxiang Shi, Jing Shao, Changzhong Wang, Guiming Yan. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1/IL-1β signaling pathway. Journal of Leukocyte Biology 2020; 108(1): 199 doi: 10.1002/JLB.3MA0120-325RR
|
| 39 |
Lufuno Ratshisusu, Omphile E. Simani, Jason T. Blackard, Selokela G. Selabe. The Impact of Drugs and Substance Abuse on Viral Pathogenesis—A South African Perspective. Viruses 2024; 16(6): 971 doi: 10.3390/v16060971
|
| 40 |
Phoenix Fung, Nikolaos Pyrsopoulos. Emerging concepts in alcoholic hepatitis. World Journal of Hepatology 2017; 9(12): 567-585 doi: 10.4254/wjh.v9.i12.567
|
| 41 |
Vatsalya Vatsalya, Ruchita Agrawal, Jane Frimodig, Shweta Srivastava, Melanie L. Schwandt. Dysregulation in Plasma ω3 Fatty Acids Concentration and Serum Zinc in Heavy Alcohol-Drinking HCV Patients. Advances in Virology 2020; 2020: 1 doi: 10.1155/2020/7835875
|